Dose-dense Capecitabine Schedule [7days on _7 Days Off] in Colorectal Cancer in Comparison With Standered Regimen

Condition(s) studied

Investigational drug(s) / intervention(s)

Arm A:Dose_dense Capecitabine in Colorectal cancer: Appling dose \_dense Capecitabine 1750mg/m2 for one week then one week off Cycle repeated every 2 weeks

Arm B : standard dose Capecitabine: Pateints will receive capecitabine 1000 mg/m2 for 2 weeks then one week off

Study summary

Dose\_dense Capecitabine Schedule in colorectal cancers

Eligibility

Primary outcome measure(s)

• 1_Quality of life assessed through EORTC_QLQ_CR29 questionaire — 2 years

Trial sites (1)

More Sohag University trials in Egypt

Other trials for the same condition